Product Categories
| Country: | United States |
|---|---|
| Tel: | 552-7181 |
| E-mail: | sales@aladdinsci.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 14078 Meridian Parkway, Riverside |
|
Aladdin Scientific Corporation is a listed company on the A-share Science and Technology Board (stock code: 688179), which has been deeply engaging in the field of scientific research reagents for more than ten years, and is a manufacturer of scientific research reagents integrating research and development, production and sales. After years of exploration, accumulation and development, it owns six major product lines of chemistry and biochemistry reagents, material sciences, drug-targeting ligands, proteins, antibodies, and I-Quip?? labware. Product line.
Relying on its own e-commerce platform (www.aladdinsci.com), Aladdin provides a huge product line covering hundreds of thousands of scientific research reagents and thousands of consumables/instruments, which are widely used in colleges and universities, scientific research institutes, medical treatment, medicine, pharmaceuticals, diagnostics, new materials, new energy, energy conservation and environmental protection, aerospace and other high-tech industries as well as their upstream and downstream enterprises. Corporation
|
|
| Product Name | MF | CAS | Details |
|---|
| GSK3368715 dihydrochloride | C20H39ClN4O2 | 1628925-77-8 | Details |
| Ganoderic acid G | C30H44O8 | 98665-22-6 | Details |
| GRGDSP | C22H37N9O10 | 91037-75-1 | Details |
| GSM-1 | C26H31ClF3NO2 | 884600-68-4 | Details |
| GNF-8625 monopyridin-N-piperazine hydrochloride | 2412055-62-8 | Details |
| Glicoricone | C21H20O6 | 161099-37-2 | Details |
| Gelsenicine | C19H22N2O3 | 82354-38-9 | Details |
| GNE-6468 | C23H16ClN3O4 | 1677668-27-7 | Details |
| Ginsenoside Rs2 | C55H92O23 | 87733-66-2 | Details |
| GDC-0425 | C18H19N5O | 1200129-48-1 | Details |
| Glabrol | C25H28O4 | 59870-65-4 | Details |
| Ganoderenic acid D | C30H40O7 | 100665-43-8 | Details |
| GLP-1R modulator L7-028 | C24H28N2O3 | 2648317-95-5 | Details |
| Glabranine | C20H20O4 | 41983-91-9 | Details |
| GSK-A1 | C29H27FN6O4S | 1416334-69-4 | Details |
| GnRH antagonist 2 | C28H27F2N9O5 | 1709823-61-9 | Details |
| Gamitrinib TPP hexafluorophosphate | C52H65F6N3O8P2 | 1131626-47-5 | Details |
| GSK598809 | C22H23F4N5OS | 863680-45-9 | Details |
| GSK-3 inhibitor 1 | C22H17ClFN5O2 | 603272-51-1 | Details |
| GSK-3β inhibitor 1 | C14H10N2O | 187325-53-7 | Details |
| GDC-0834 S-enantiomer | C33H36N6O3S | 1133432-50-4 | Details |
| Galidesivir hydrochloride | C11H16ClN5O3 | 222631-44-9 | Details |
| Ginsenoside Rd2 | C47H80O17 | 83480-64-2 | Details |
| Gelsevirine | C21H24N2O3 | 38990-03-3 | Details |
| GSK2593074A | C27H23N5OS | 1337531-06-2 | Details |
| GNE-0439 | C21H31NO3 | 1241902-40-8 | Details |
| GSK256066 Trifluoroacetate | C29H27F3N4O7S | 1415560-64-3 | Details |
| Gigantol | C16H18O4 | 67884-30-4 | Details |
| Ganoderenic acid E | C30H40O8 | 110241-23-1 | Details |
| Givosiran | 1639325-43-1 | Details |
| GSK8573 | C20H21NO3 | 1693766-04-9 | Details |
| GLPG2938 | C20H19F6N7O2 | 2130996-00-6 | Details |
| (+)Gomisin M2 | C22H26O6 | 82425-45-4 | Details |
| GSK3-IN-3 | C24H35N3O4 | 331963-27-0 | Details |
| GNE-7915 tosylate | C26H29F4N5O6S | 2070015-00-6 | Details |
| Glucocorticoid receptor agonist | C20H20F4N2O2 | 1245526-82-2 | Details |
| Garcinone D | C24H28O7 | 107390-08-9 | Details |
| GPR120 Agonist 3 | C19H23ClF3NO3 | 1599477-75-4 | Details |
| Ginsenoside Rh4 | C36H60O8 | 174721-08-5 | Details |
| Ganoderic acid F | C32H42O9 | 98665-15-7 | Details |
| Ginsenoside Rs1 | C55H92O23 | 87733-67-3 | Details |
| GNE 220 hydrochloride | C25H27ClN8 | 2448286-21-1 | Details |
| GSK-3/CDK5/CDK2-IN-1 | C21H22N4O2 | 395074-72-3 | Details |
| Glucocorticoid receptor agonist-2 | C34H35F2NO7 | 2166378-92-1 | Details |
| Ginsenoside Rk2 | C36H60O7 | 364779-14-6 | Details |
| Galegine hydrochloride | C6H14ClN3 | 2368870-39-5 | Details |
| GSK3494245 | C21H23FN6O2 | 2080410-41-7 | Details |
| Ginsenoside Ra2 | C58H98O26 | 83459-42-1 | Details |
| GNE-0946 | C22H12ClF3N2O4 | 1677667-24-1 | Details |
| (E/Z)-GSK-3β inhibitor 1 | C14H10N2O | 3367-88-2 | Details |
| G12 | C52H95N15O15 | 162550-82-5 | Details |
| Glucose dehydrogenase (GDH) | NULL | 9028-53-9 | Details |
| GN25 | C15H14O6S | 1227401-27-5 | Details |
| Galantamine Hydrobromide Lycoremine | C17H19NO3 | 510-77-0 | Details |
| Glutaminase-IN-1 | C26H24F3N7O3Se | 2247127-79-1 | Details |
| GSK-269984A | C20H15Cl2FNNaO3 | 892664-04-9 | Details |
| Guaiacin | C20H24O4 | 36531-08-5 | Details |
| 8-Geranyl daidzein | C25H26O4 | 1072940-16-9 | Details |
| 20(R)-Ginsenoside Rg2 | C42H72O13 | 80952-72-3 | Details |
| GB1107 | C20H16Cl2F3N3O4S | 1978336-61-6 | Details |
| Gumelutamide | C22H21ClN6O | 1831085-48-3 | Details |
| GNA002 | C42H55NO8 | 1385035-79-9 | Details |
| Garsorasib | C32H32F2N8O2 | 2559761-14-5 | Details |
| Gelucire 44/14 | 121548-04-7 | Details |
| (-)Gomisin L1 | C22H26O6 | 82425-43-2 | Details |
| GDC-0276 | C24H31FN2O4S | 1494581-70-2 | Details |
| Giredestrant | C27H31F5N4O | 1953133-47-5 | Details |
| GLP-26 | C19H17F2N3O3 | 2133017-36-2 | Details |
| GDP-α-D-mannose disodium | C16H23N5Na2O16P2 | 148296-46-2 | Details |
| Ginsenoside Ra1 | C58H98O26 | 83459-41-0 | Details |
| gamma-secretase modulator 1 hydrochloride | C24H25ClN4OS | 2741571-83-3 | Details |
| GalNac-L96 | 1159408-62-4 | Details |
| Ganodermanontriol | C30H48O4 | 106518-63-2 | Details |
| GSK1820795A | C35H34N8 | 2650253-86-2 | Details |
| GW-406381 | C21H19N3O3S | 221148-46-5 | Details |
| GW768505A free base | C27H19F4N5O3 | 501693-25-0 | Details |
| Ginsenoside Ra3 | C59H100O27 | 90985-77-6 | Details |
| Gomisin G | C30H32O9 | 62956-48-3 | Details |
| Glucocorticoid receptor agonist-2 Ala-Ala-Mal | C47H50F2N4O12 | 2166376-64-1 | Details |
| GSK726701A | C24H22FNO5 | 945721-87-9 | Details |
| Ginsenoside Rh8 | C36H60O9 | 343780-69-8 | Details |
| GSK 690 Hydrochloride | C24H23N3O.ClH | 2436760-79-9 | Details |
| GPR40 Activator 2 | C28H29NO6S2 | 1312787-30-6 | Details |
| GDC-0575 dihydrochloride | C16H21BrClN5O | 1657014-42-0 | Details |
| Glucosylceramide synthase-IN-2 | C22H20F3N3O4 | 2597958-02-4 | Details |
| Ganolactone A | C27H36O6 | 173268-82-1 | Details |
| 20-gluco-ginsenoside Rf | C48H82O19 | 68406-27-9 | Details |
| GSK-3685032 | C22H24N6OS | 2170137-61-6 | Details |
| Glycolithocholic acid 3-sulfate | C26H43NO7S | 15324-64-8 | Details |
| GSK2245035 | C20H34N6O2 | 1207629-49-9 | Details |
| Glycolic acid-d2 | C2H2D2O3 | 75502-10-2 | Details |
| GPR40 Activator 1 | C31H31NO3S | 1309435-60-6 | Details |
| Glycoside O-4 | C39H62O15S | 94898-61-0 | Details |
| Ginsenoside F5 | C41H70O13 | 189513-26-6 | Details |
| Ginsenoside Ra6 | C58H96O24 | 1346522-89-1 | Details |
| Gensenoside Rh7 | C36H60O9 | 343780-68-7 | Details |
| Gartanin | C23H24O6 | 33390-42-0 | Details |
| Gefitinib impurity 2 | C15H23N3O4 | 246512-44-7 | Details |
| GSK-872 hydrochloride | C19H18ClN3O2S2 | 2703752-81-0 | Details |
| Glyco-diosgenin | C56H92O25 | 1402423-29-3 | Details |
| Product Total： Product Page： | ||||
| 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 | ||||